Luke Izzo
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Biological Psychiatry top 10%
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
-
- Metabolism and Genetic Disorders 2
- Co-authors
- Kathryn E. Wellen (7 shared papers)Nathaniel W. Snyder (4 shared papers)Sophie Trefely (4 shared papers)Alessandro Carrer (2 shared papers)Cholsoon Jang (1 shared paper)Xianfeng Zeng (1 shared paper)Joshua D. Rabinowitz (1 shared paper)Terence P. Gade (1 shared paper)
- Journals
- Cancer Research (2 papers)Nature (2 papers)Science Advances (1 paper)Cell (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesItalyAustria
In The Last Decade
Luke Izzo
11 papers receiving 1.2k citations
Luke Izzo's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 227
- Biological Psychiatry 36
- Neurology 167
- Endocrinology, Diabetes and Metabolism 156
- Molecular Biology 610
Countries citing papers authored by Luke Izzo
This map shows the geographic impact of Luke Izzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Izzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Izzo more than expected).
Fields of papers citing papers by Luke Izzo
This network shows the impact of papers produced by Luke Izzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Izzo. The network helps show where Luke Izzo may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Izzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate Hit paper breakdown → | 2020 | 442 |
| 2 | Serotonin reduction in post-acute sequelae of viral infection Hit paper breakdown → | 2023 | 246 |
| 3 | 2019 | 162 | |
| 4 | 2020 | 120 | |
| 5 | 2021 | 87 | |
| 6 | 2023 | 85 | |
| 7 | 2022 | 49 | |
| 8 | 2020 | 40 | |
| 9 | 2023 | 6 | |
| 10 | 2025 | 3 | |
| 11 | 2025 | 1 | |
| 12 | 2026 | 0 |
About Luke Izzo
Luke Izzo is a scholar working on Cancer Research, Clinical Biochemistry, Molecular Biology, Biological Psychiatry and Urology, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Metabolism and Genetic Disorders (2 papers), Mitochondrial Function and Pathology (2 papers), Epigenetics and DNA Methylation (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Tryptophan and brain disorders (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Cancer Research (227 citations), Biological Psychiatry (36 citations), Neurology (167 citations), Endocrinology, Diabetes and Metabolism (156 citations) and Molecular Biology (610 citations). Luke Izzo has collaborated with scholars based in United States, Italy and Austria. Frequent co-authors include Kathryn E. Wellen, Nathaniel W. Snyder, Sophie Trefely, Alessandro Carrer, Cholsoon Jang, Xianfeng Zeng, Joshua D. Rabinowitz, Terence P. Gade, Sully Fernandez and Zachary T. Schug. Their work appears in journals such as Cancer Research, Nature, Science Advances, Cell and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.